Literature DB >> 2381541

Effects of changes in stimulus contingency on visual extinction.

R F Kaplan1, M Verfaellie, L D DeWitt, L R Caplan.   

Abstract

Left visual field (LVF) extinction during double simultaneous stimulation (DSS) is common in patients with right cerebral lesions. A postulate is that during DSS, the intact left hemisphere's limited attentional capacity is directed to right hemispace, resulting in LVF extinction. External cueing may help direct attention to the LVF and improve performance. In the present study, we varied patterns of unilateral stimulation preceding DSS in an attempt to redirect attention through expectancy. Nine patients (7 stroke, 2 tumor) with right hemisphere lesions each had 40 DSS trials with the distribution of unilateral stimulation trials systematically varied. Mean extinction percentages on DSS trials were 17% following 5 right unilateral trials, 30% following 1 right unilateral trial, 52% following 1 left unilateral trial, and 63% following 5 left unilateral trials. These findings indicate that the probability of extinction decreases following unilateral stimulation to the right visual field and increases following unilateral stimulation to the LVF. These results suggest that expectancy alters the attentional bias which mediates extinction.

Entities:  

Mesh:

Year:  1990        PMID: 2381541     DOI: 10.1212/wnl.40.8.1299

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Anatomical correlates of visual and tactile extinction in humans: a clinical CT scan study.

Authors:  G Vallar; M L Rusconi; L Bignamini; G Geminiani; D Perani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

2.  Extinction during time controlled direct retinal stimulation after recovery from right hemispheric stroke.

Authors:  R F Kaplan; R A Cohen; A Rosengart; A E Elsner; T R Hedges; L R Caplan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.